Sodium Polystyrene Sulfonate
These highlights do not include all the information needed to use Sodium Polystyrene Sulfonate Powder, for Suspension safely and effectively. See full prescribing information for Sodium Polystyrene Sulfonate Powder, for Suspension.Sodium Polystyrene Sulfonate Powder, for Suspension, for oral or rectal useInitial U.S. Approval: 1958
Approved
Approval ID
875d5288-db99-4440-8290-d9192bde6eee
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 28, 2022
Manufacturers
FDA
PuraCap Laboratories, LLC
DUNS: 080210964
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sodium Polystyrene Sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code24658-760
Application NumberANDA202333
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Polystyrene Sulfonate
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 21, 2018
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIB